Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Determining the Quantitative Principles of T Cell Response to Antigenic Disparity in Stem Cell Transplantation.
Salman A, Koparde V, Hall CE, Jameson-Lee M, Roberts C, Serrano M, AbdulRazzaq B, Meier J, Kennedy C, Manjili MH, Spellman SR, Wijesinghe D, Hashmi S, Buck G, Qayyum R, Neale M, Reed J, Toor AA. Salman A, et al. Among authors: toor aa. Front Immunol. 2018 Oct 11;9:2284. doi: 10.3389/fimmu.2018.02284. eCollection 2018. Front Immunol. 2018. PMID: 30364159 Free PMC article. Review.
Favorable outcomes in patients with high donor-derived T cell count after in vivo T cell-depleted reduced-intensity allogeneic stem cell transplantation.
Toor AA, Sabo RT, Chung HM, Roberts C, Manjili RH, Song S, Williams DC Jr, Edmiston W, Gatesman ML, Edwards RW, Ferreira-Gonzalez A, Clark WB, Neale MC, McCarty JM, Manjili MH. Toor AA, et al. Biol Blood Marrow Transplant. 2012 May;18(5):794-804. doi: 10.1016/j.bbmt.2011.10.011. Epub 2011 Oct 17. Biol Blood Marrow Transplant. 2012. PMID: 22005648 Free PMC article. Clinical Trial.
Anti-thymocyte globulin for conditioning in matched unrelated donor hematopoietic cell transplantation provides comparable outcomes to matched related donor recipients.
Portier DA, Sabo RT, Roberts CH, Fletcher DS, Meier J, Clark WB, Neale MC, Manjili MH, McCarty JM, Chung HM, Toor AA. Portier DA, et al. Among authors: toor aa. Bone Marrow Transplant. 2012 Dec;47(12):1513-9. doi: 10.1038/bmt.2012.81. Epub 2012 May 14. Bone Marrow Transplant. 2012. PMID: 22580767 Free PMC article.
Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity.
Toor AA, Payne KK, Chung HM, Sabo RT, Hazlett AF, Kmieciak M, Sanford K, Williams DC, Clark WB, Roberts CH, McCarty JM, Manjili MH. Toor AA, et al. Br J Haematol. 2012 Sep;158(6):700-11. doi: 10.1111/j.1365-2141.2012.09225.x. Epub 2012 Jul 23. Br J Haematol. 2012. PMID: 22816680 Free PMC article. Clinical Trial.
Immunotherapy of cancer: reprogramming tumor-immune crosstalk.
Payne KK, Toor AA, Wang XY, Manjili MH. Payne KK, et al. Among authors: toor aa. Clin Dev Immunol. 2012;2012:760965. doi: 10.1155/2012/760965. Epub 2012 Oct 11. Clin Dev Immunol. 2012. PMID: 23097673 Free PMC article. Review.
99 results